Neurohormonal and Renal Effects of 14-Day Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction

Circ Heart Fail. 2024 Dec 24:e012167. doi: 10.1161/CIRCHEARTFAILURE.124.012167. Online ahead of print.

Authors

Kristoffer Berg-Hansen^{1

2}, Nigopan Gopalasingam^{1

2}, Kristian Hylleberg Christensen^{1

2}, Mads Svart^{3

2}, Nikolaj Rittig^{3

2}, Roni Nielsen¹, Kent Lodberg¹, Niels Møller^{3

2}, Henrik Wiggers^{1

2}

Affiliations

¹ Department of Cardiology, Aarhus University Hospital, Denmark. (K.B.-H., N.G., K.H.C., R.N., K.L., H.W.).
² Department of Clinical Medicine, Faculty of Health, Aarhus University, Denmark (K.B.-H., N.G., K.H.C., M.S., N.R., N.M., H.W.).
³ Department of Endocrinology and Metabolism, Aarhus University Hospital, Denmark. (M.S., N.R., N.M.).

PMID: 39717923
DOI: 10.1161/CIRCHEARTFAILURE.124.012167

No abstract available

Keywords: 3-hydroxybutyric acid; aldosterone; erythropoietin; heart failure; renin.

Publication types

Letter